Cargando…

Mesenteric Plexiform Neurofibroma as a Cause of Weight Loss and Chronic Diarrhea in a Patient with YPEL3 Variant

Mesenteric plexiform neurofibroma is a subtype of plexiform neurofibroma that involves the mesentery and causes a variety of gastrointestinal complaints. Plexiform neurofibroma is classically found in patients with neurofibromatosis type 1, although genetic contributions to plexiform neurofibroma pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorbounova, Irina, Lenahan, Arthur, Wenger, Tara Lynn, Rudzinski, Erin, Tang, Elizabeth Ren-Yee, Smith, Caitlin A., Wendel, Danielle, Horslen, Simon, Ambartsumyan, Lusine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191502/
https://www.ncbi.nlm.nih.gov/pubmed/37205972
http://dx.doi.org/10.1097/PG9.0000000000000098
_version_ 1785043475725549568
author Gorbounova, Irina
Lenahan, Arthur
Wenger, Tara Lynn
Rudzinski, Erin
Tang, Elizabeth Ren-Yee
Smith, Caitlin A.
Wendel, Danielle
Horslen, Simon
Ambartsumyan, Lusine
author_facet Gorbounova, Irina
Lenahan, Arthur
Wenger, Tara Lynn
Rudzinski, Erin
Tang, Elizabeth Ren-Yee
Smith, Caitlin A.
Wendel, Danielle
Horslen, Simon
Ambartsumyan, Lusine
author_sort Gorbounova, Irina
collection PubMed
description Mesenteric plexiform neurofibroma is a subtype of plexiform neurofibroma that involves the mesentery and causes a variety of gastrointestinal complaints. Plexiform neurofibroma is classically found in patients with neurofibromatosis type 1, although genetic contributions to plexiform neurofibroma pathogenesis are heterogeneous. We report the first case of mesenteric plexiform neurofibroma in a patient with a YPEL3 pathogenic variant. This patient presented with growth failure, generalized abdominal pain and chronic diarrhea. She was confirmed to have mesenteric plexiform neurofibroma on histopathology and targeted sequencing on affected tissue confirmed that there were no neurofibromatosis type 1 variants present. Given that this patient’s mesenteric plexiform neurofibroma is associated with YPEL3 dysfunction, she is unlikely to benefit from MEK inhibitors, which are the newly approved treatment for inoperable plexiform neurofibroma in patients with neurofibromatosis type 1.
format Online
Article
Text
id pubmed-10191502
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins, Inc.
record_format MEDLINE/PubMed
spelling pubmed-101915022023-05-18 Mesenteric Plexiform Neurofibroma as a Cause of Weight Loss and Chronic Diarrhea in a Patient with YPEL3 Variant Gorbounova, Irina Lenahan, Arthur Wenger, Tara Lynn Rudzinski, Erin Tang, Elizabeth Ren-Yee Smith, Caitlin A. Wendel, Danielle Horslen, Simon Ambartsumyan, Lusine JPGN Rep Case Report Mesenteric plexiform neurofibroma is a subtype of plexiform neurofibroma that involves the mesentery and causes a variety of gastrointestinal complaints. Plexiform neurofibroma is classically found in patients with neurofibromatosis type 1, although genetic contributions to plexiform neurofibroma pathogenesis are heterogeneous. We report the first case of mesenteric plexiform neurofibroma in a patient with a YPEL3 pathogenic variant. This patient presented with growth failure, generalized abdominal pain and chronic diarrhea. She was confirmed to have mesenteric plexiform neurofibroma on histopathology and targeted sequencing on affected tissue confirmed that there were no neurofibromatosis type 1 variants present. Given that this patient’s mesenteric plexiform neurofibroma is associated with YPEL3 dysfunction, she is unlikely to benefit from MEK inhibitors, which are the newly approved treatment for inoperable plexiform neurofibroma in patients with neurofibromatosis type 1. Lippincott Williams & Wilkins, Inc. 2021-07-12 /pmc/articles/PMC10191502/ /pubmed/37205972 http://dx.doi.org/10.1097/PG9.0000000000000098 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer on behalf of European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Gorbounova, Irina
Lenahan, Arthur
Wenger, Tara Lynn
Rudzinski, Erin
Tang, Elizabeth Ren-Yee
Smith, Caitlin A.
Wendel, Danielle
Horslen, Simon
Ambartsumyan, Lusine
Mesenteric Plexiform Neurofibroma as a Cause of Weight Loss and Chronic Diarrhea in a Patient with YPEL3 Variant
title Mesenteric Plexiform Neurofibroma as a Cause of Weight Loss and Chronic Diarrhea in a Patient with YPEL3 Variant
title_full Mesenteric Plexiform Neurofibroma as a Cause of Weight Loss and Chronic Diarrhea in a Patient with YPEL3 Variant
title_fullStr Mesenteric Plexiform Neurofibroma as a Cause of Weight Loss and Chronic Diarrhea in a Patient with YPEL3 Variant
title_full_unstemmed Mesenteric Plexiform Neurofibroma as a Cause of Weight Loss and Chronic Diarrhea in a Patient with YPEL3 Variant
title_short Mesenteric Plexiform Neurofibroma as a Cause of Weight Loss and Chronic Diarrhea in a Patient with YPEL3 Variant
title_sort mesenteric plexiform neurofibroma as a cause of weight loss and chronic diarrhea in a patient with ypel3 variant
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191502/
https://www.ncbi.nlm.nih.gov/pubmed/37205972
http://dx.doi.org/10.1097/PG9.0000000000000098
work_keys_str_mv AT gorbounovairina mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant
AT lenahanarthur mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant
AT wengertaralynn mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant
AT rudzinskierin mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant
AT tangelizabethrenyee mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant
AT smithcaitlina mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant
AT wendeldanielle mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant
AT horslensimon mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant
AT ambartsumyanlusine mesentericplexiformneurofibromaasacauseofweightlossandchronicdiarrheainapatientwithypel3variant